BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6423894)

  • 1. Rejection of established mouse pancreatic islet allografts by active immunization requires class I (H-2 K, D) antigen disparities.
    Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
    J Surg Res; 1984 Apr; 36(4):332-40. PubMed ID: 6423894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in susceptibility to rejection of mouse pancreatic islet allografts disparate for class I or class II major histocompatibility antigens.
    Morrow CE; Sutherland DE; Steffes MW; Kaufman D; Najarian JS; Bach FH
    J Surg Res; 1983 Apr; 34(4):358-66. PubMed ID: 6403774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of rejection of established islet allografts by third-party thyroid allografts and splenic dendritic cells.
    Kover K; Moore WV
    Diabetes; 1991 Jun; 40(6):754-8. PubMed ID: 2040391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2 antigen class: effect on mouse islet allograft rejection.
    Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
    Science; 1983 Mar; 219(4590):1337-9. PubMed ID: 6402817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of donor-specific tolerance in mice with established anti-Ia-treated islet allografts.
    Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
    Transplantation; 1983 Dec; 36(6):691-4. PubMed ID: 6419424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
    Li H; Colson YL; Ildstad ST
    Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characteristics of purified pancreatic islet grafts.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplantation; 1986 Oct; 42(4):387-90. PubMed ID: 3094210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum.
    Gotoh M; Porter J; Monaco AP; Maki T
    Transplantation; 1988 Feb; 45(2):429-33. PubMed ID: 2449750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet transplantation in mice differing in the I and S subregions of the H-2 complex. Effects of presensitization with skin allografts.
    Scott J; Steffes MW; Lernmark A
    Scand J Immunol; 1982 Jul; 16(1):9-15. PubMed ID: 6812214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surface concentration of H-2 antigens on mouse pancreatic beta-cells and islet cell transplantation.
    Parr EL; Oliver JR; King NJ
    Diabetes; 1982 Aug; 31 Suppl 4():1-10. PubMed ID: 6819959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells.
    Oluwole SF; Chowdhury NC; Fawwaz RA
    Transplantation; 1993 Jun; 55(6):1389-95. PubMed ID: 8516824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.